56 related articles for article (PubMed ID: 20013816)
1. Randomized double-blind placebo-controlled trial on the potential modes of action of SheaFlex70 in osteoarthritis.
Cheras PA; Myers SP; Paul-Brent PA; Outerbridge KH; Nielsen GV
Phytother Res; 2010 Aug; 24(8):1126-31. PubMed ID: 20013816
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
[TBL] [Abstract][Full Text] [Related]
3. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.
Winther K; Apel K; Thamsborg G
Scand J Rheumatol; 2005; 34(4):302-8. PubMed ID: 16195164
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial.
Grube B; Grünwald J; Krug L; Staiger C
Phytomedicine; 2007 Jan; 14(1):2-10. PubMed ID: 17169543
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
[TBL] [Abstract][Full Text] [Related]
6. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
Altman RD; Moskowitz R
J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect.
Maheu E; Mazières B; Valat JP; Loyau G; Le Loët X; Bourgeois P; Grouin JM; Rozenberg S
Arthritis Rheum; 1998 Jan; 41(1):81-91. PubMed ID: 9433873
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
10. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
Peloso PM; Bellamy N; Bensen W; Thomson GT; Harsanyi Z; Babul N; Darke AC
J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
12. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
13. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
Garrison R; Chambliss WG
Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
[TBL] [Abstract][Full Text] [Related]
14. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.
Lambert RG; Hutchings EJ; Grace MG; Jhangri GS; Conner-Spady B; Maksymowych WP
Arthritis Rheum; 2007 Jul; 56(7):2278-87. PubMed ID: 17599747
[TBL] [Abstract][Full Text] [Related]
15. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
16. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M
Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
Rejnmark L; Buus NH; Vestergaard P; Heickendorff L; Andreasen F; Larsen ML; Mosekilde L
J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496
[TBL] [Abstract][Full Text] [Related]
18. Multicenter studies in the United States and Canada of meclofenamate sodium in osteoarthritis of the hip and knee. Double-blind comparison with placebo and long-term experience.
Petrick TJ; Bovenkerk WE
Arzneimittelforschung; 1983; 33(4A):644-8. PubMed ID: 6349649
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
